Sialic acid blockade in dendritic cells enhances CD8+ T cell responses by facilitating high-avidity interactions

被引:22
作者
Balneger, N. [1 ]
Cornelissen, L. A. M. [1 ]
Wassink, M. [1 ]
Moons, S. J. [2 ]
Boltje, T. J. [2 ]
Bar-Ephraim, Y. E. [3 ]
Das, K. K. [3 ]
Sondergaard, J. N. [4 ]
Bull, C. [1 ,5 ]
Adema, G. J. [1 ]
机构
[1] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Radiat Oncol, Radiotherapy & OncoImmunol Lab,Med Ctr, Geert Grootepl Zuid 32, NL-6525 GA Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Inst Mol & Mat, Cluster Mol Chem, Nijmegen, Netherlands
[3] LUMICKS, Pilotenstr 41, NL-1059 CH Amsterdam, Netherlands
[4] Osaka Univ, Ctr Infect Dis Educ & Res, Osaka 5650871, Japan
[5] Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands
关键词
Glycosylation; Sialic acid; Dendritic cell; Cell avidity; CD8(+) T cell; Sialic acid blockade; SIALYLATION; IMMUNOTHERAPY; NEURAMINIDASE; ACTIVATION; MONOCYTES; ADHESION; SURFACE;
D O I
10.1007/s00018-021-04027-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sialic acids are negatively charged carbohydrates that cap the glycans of glycoproteins and glycolipids. Sialic acids are involved in various biological processes including cell-cell adhesion and immune recognition. In dendritic cells (DCs), the major antigen-presenting cells of the immune system, sialic acids emerge as important regulators of maturation and interaction with other lymphocytes including T cells. Many aspects of how sialic acids regulate DC functions are not well understood and tools and model systems to address these are limited. Here, we have established cultures of murine bone marrow-derived DCs (BMDCs) that lack sialic acid expression using a sialic acid-blocking mimetic Ac(5)3F(ax)Neu5Ac. Ac(5)3F(ax)Neu5Ac treatment potentiated BMDC activation via toll-like receptor (TLR) stimulation without affecting differentiation and viability. Sialic acid blockade further increased the capacity of BMDCs to induce antigen-specific CD8(+) T cell proliferation. Transcriptome-wide gene expression analysis revealed that sialic acid mimetic treatment of BMDCs induces differential expression of genes involved in T cell activation, cell-adhesion, and cell-cell interactions. Subsequent cell clustering assays and single cell avidity measurements demonstrated that BMDCs with reduced sialylation form higher avidity interactions with CD8(+) T cells. This increased avidity was detectable in the absence of antigens, but was especially pronounced in antigen-dependent interactions. Together, our data show that sialic acid blockade in BMDCs ameliorates maturation and enhances both cognate T cell receptor-MHC-dependent and independent T cell interactions that allow for more robust CD8(+) T cell responses.
引用
收藏
页数:15
相关论文
共 48 条
  • [1] Neu1 Sialidase and Matrix Metalloproteinase-9 Cross-talk Is Essential for Toll-like Receptor Activation and Cellular Signaling
    Abdulkhalek, Samar
    Amith, Schammim Ray
    Franchuk, Susan L.
    Jayanth, Preethi
    Guo, Merry
    Finlay, Trisha
    Gilmour, Alanna
    Guzzo, Christina
    Gee, Katrina
    Beyaert, Rudi
    Szewczuk, Myron R.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (42) : 36532 - 36549
  • [2] Neu1 desialylation of sialyl α-2,3-linked β-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling
    Amith, Schammim Ray
    Jayanth, Preethi
    Franchuk, Susan
    Finlay, Trisha
    Seyrantepe, Volkan
    Beyaert, Rudi
    Pshezhetsky, Alexey V.
    Szewczuk, Myron R.
    [J]. CELLULAR SIGNALLING, 2010, 22 (02) : 314 - 324
  • [3] The direct and indirect effects of glycans on immune function
    Baum, Linda G.
    Cobb, Brian A.
    [J]. GLYCOBIOLOGY, 2017, 27 (07) : 619 - 624
  • [4] Interaction of Polysialic Acid with CCL21 Regulates the Migratory Capacity of Human Dendritic Cells
    Bax, Marieke
    van Vliet, Sandra J.
    Litjens, Manja
    Garcia-Vallejo, Juan J.
    van Kooyk, Yvette
    [J]. PLOS ONE, 2009, 4 (09):
  • [5] Probing the binding specificities of human Siglecs by cell-based glycan arrays
    Bull, Christian
    Nason, Rebecca
    Sun, Lingbo
    Van Coillie, Julie
    Sorensen, Daniel Madriz
    Moons, Sam J.
    Yang, Zhang
    Arbitman, Steven
    Fernandes, Steve M.
    Furukawa, Sanae
    McBride, Ryan
    Nycholat, Corwin M.
    Adema, Gosse J.
    Paulson, James C.
    Schnaar, Ronald L.
    Boltje, Thomas J.
    Clausen, Henrik
    Narimatsu, Yoshiki
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (17)
  • [6] Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity
    Bull, Christian
    Boltje, Thomas J.
    Balneger, Natasja
    Weischer, Sarah M.
    Wassink, Melissa
    van Gemst, Jasper J.
    Bloemendal, Victor R.
    Boon, Louis
    van der Vlag, Johan
    Heise, Torben
    den Brok, Martijn H.
    Adema, Gosse J.
    [J]. CANCER RESEARCH, 2018, 78 (13) : 3574 - 3588
  • [7] Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation
    Bull, Christian
    Collado-Camps, Estel
    Kers-Rebel, Esther D.
    Heise, Torben
    Sondergaard, Jonas N.
    den Brok, Martijn H.
    Schulte, Barbara M.
    Boltje, Thomas J.
    Adema, Gosse J.
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2017, 95 (04) : 408 - 415
  • [8] Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis
    Bull, Christian
    Heise, Torben
    Adema, Gosse J.
    Boltje, Thomas J.
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2016, 41 (06) : 519 - 531
  • [9] Targeted Delivery of a Sialic Acid-Blocking Glycomimetic to Cancer Cells Inhibits Metastatic Spread
    Bull, Christian
    Boltje, Thomas Jan
    van Dinther, Eric A. W.
    Peters, Timo
    de Graaf, Annemarie M. A.
    Leusen, Jeanette H. W.
    Kreutz, Martin
    Figdor, Carl G.
    den Brok, Martijn H.
    Adema, Gosse J.
    [J]. ACS NANO, 2015, 9 (01) : 733 - 745
  • [10] Targeting Aberrant Sialylation in Cancer Cells Using a Fluorinated Sialic Acid Analog Impairs Adhesion, Migration, and In Vivo Tumor Growth
    Bull, Christian
    Boltje, Thomas J.
    Wassink, Melissa
    de Graaf, Annemarie M. A.
    van Delft, Floris L.
    den Brok, Martijn H.
    Adema, Gosse J.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (10) : 1935 - 1946